Mitsubishi UFJ Trust & Banking Corp Has $6.36 Million Stake in DaVita Inc. $DVA

Key Points

• Mitsubishi UFJ Trust & Banking cut its DaVita stake by 52.6% in Q4 to 55,973 shares, leaving a holding worth about $6.36 million (roughly 0.08% of the company).
• DaVita reported a Q that beat estimates with $3.40 EPS and revenue up 9.9% year-over-year, and set FY2026 guidance of 13.60–15.00 EPS (analysts forecast ~14.16 EPS).
• Institutional ownership is high at 90.12%; analysts’ consensus is a Hold rating (1 Buy, 5 Hold, 1 Sell) with an average price target of $155.80, and the stock trades near $151.80 with a market cap of $10.14 billion.

Mitsubishi UFJ Trust & Banking Corp trimmed its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 52.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 55,973 shares of the company's stock after selling 62,200 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.08% of DaVita worth $6,364,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DVA. National Pension Service bought a new stake in shares of DaVita in the 3rd quarter worth $1,305,000. Todd Asset Management LLC bought a new position in DaVita in the 3rd quarter valued at $21,842,000. Intech Investment Management LLC grew its stake in DaVita by 122.4% in the 3rd quarter. Intech Investment Management LLC now owns 27,441 shares of the company's stock valued at $3,646,000 after purchasing an additional 15,104 shares during the period. Doma Perpetual Capital Management LLC grew its stake in DaVita by 23.3% in the 3rd quarter. Doma Perpetual Capital Management LLC now owns 355,574 shares of the company's stock valued at $47,245,000 after purchasing an additional 67,214 shares during the period. Finally, Nordea Investment Management AB grew its stake in DaVita by 18.0% in the 4th quarter. Nordea Investment Management AB now owns 338,192 shares of the company's stock valued at $38,321,000 after purchasing an additional 51,607 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

DVA has been the subject of a number of recent analyst reports. Zacks Research downgraded DaVita from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 6th. Truist Financial set a $158.00 price objective on DaVita in a research note on Thursday, February 5th. Barclays upped their price objective on DaVita from $143.00 to $158.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 3rd. UBS Group upped their price objective on DaVita from $186.00 to $190.00 and gave the company a "buy" rating in a research note on Wednesday, February 4th. Finally, Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research note on Saturday, February 21st. One investment analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, DaVita presently has an average rating of "Hold" and an average price target of $155.80.

DaVita Trading Down 2.2%

Shares of NYSE DVA opened at $151.80 on Friday. The stock has a fifty day simple moving average of $151.18 and a two-hundred day simple moving average of $131.48. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $159.42. The firm has a market cap of $10.14 billion, a price-to-earnings ratio of 15.32, a price-to-earnings-growth ratio of 0.53 and a beta of 0.84.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Monday, February 2nd. The company reported $3.40 earnings per share for the quarter, beating the consensus estimate of $3.24 by $0.16. DaVita had a negative return on equity of 413.18% and a net margin of 5.47%.The business had revenue of $3.62 billion during the quarter, compared to analyst estimates of $3.51 billion. During the same period in the prior year, the company earned $2.24 earnings per share. DaVita's revenue was up 9.9% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS. Analysts forecast that DaVita Inc. will post 14.16 EPS for the current year.

About DaVita

DaVita Inc NYSE: DVA is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.